Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

rivaroxaban

rivaroxaban
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Xarelto (liquid formulation) SUSPENSION, ORAL 1 mg/mL      
Xarelto TABLET, ORAL 2.5 mg, 10 mg, 15 mg, 20 mg      
VIEW MORE Direct Factor Xa Inhibitors
CLASS
20120414
Comments:

Xarelto is approved for sample use in HH Endocrinology and Diabetes Clinics.

Rivaroxaban liquid formulation is restricted to use in pediatric patients.

Xarelto medication guide

30 Day Free Trial

copay card

For the treatment of DVT/PE - Pharmacists may automatically enter the missing maintenance regimen (20 mg Daily) of rivaroxaban at the time of verifying the initial regimen (15 mg BID x 21 days).

Automatic renal adjustment per guidelines. Renal Adjustment Guidelines


Renal Dose Adjustment For Nonvalvular A-Fib:
Normal dose: 20 mg once daily

CrCl 15-50 mL/min ---> Adjust to 15 mg once daily

 

NO renal dose adjustment for DVT/PE

 

Reviewed: July 26, 2011

Updated: February 2021

Last updated: Apr. 17, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved